Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments

Financial Instruments
6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Financial Instruments Financial Instruments
        The composition of financial instruments is as follows:
June 30, 2020 December 31, 2019
(in thousands)
Interest rate swap $ 85    $ 37   
The fair value of the Company’s financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants and is recorded using a hierarchical disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The levels are described below:
Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.
Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.
Level 3: Unobservable inputs are used when little or no market data is available.
The Company classifies its financial instrument within Level 2 of the fair value hierarchy on the basis of models utilizing market observable inputs. The interest rate swap has been valued on the basis of valuations provided by third-party pricing services, as derived from standard valuation or pricing models. Market-based observable inputs for the interest rate swap include one-month LIBOR-based yield curves over the term of the swap. The Company reviews third-party pricing provider models, key inputs and assumptions and understands the pricing processes at its third-party providers in determining the overall reasonableness of the fair value of its Level 2 financial instruments. The Company also considers the risk of nonperformance by assessing the swap counterparty’s credit risk in the estimate of fair value of the interest rate swap. As of June 30, 2020 and December 31, 2019, the Company has not made any adjustments to the valuations obtained from its third-party pricing providers. 
The following table presents a summary of the Company’s financial instruments that are measured on a recurring basis:
Fair Value Measurements
Balance Quoted Prices
in Active Markets for Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
(Level 3)
(in thousands)
Interest rate swap, June 30, 2020 $ 85    $ —    $ 85    $ —   
Interest rate swap, December 31, 2019 $ 37    $ —    $ 37    $ —   

The following table summarizes activity for the interest rate swap:
Six Months Ended
June 30,
June 30,
(in thousands)
Interest rate swap asset (liability)
Beginning balance $ (37)   $ 1,623   
Unrealized loss recognized in other comprehensive income (loss) (48)   (1,405)  
Ending balance $ (85)   $ 218   
There were no transfers between Level 1, Level 2 or Level 3 financial instruments in the six months ended June 30, 2020 and 2019.
Financial Instruments Not Recorded at Fair Value on a Recurring Basis

Some of the Company’s financial instruments are not measured at fair value on a recurring basis but are recorded at amounts that approximate fair value due to their liquid or short-term nature. Such financial assets and financial liabilities include: cash and cash equivalents, restricted cash, net receivables, certain other assets, accounts payable, accrued price protection liability, accrued expenses, accrued compensation costs, and other current liabilities.

The Company’s long-term debt is not recorded at fair value on a recurring basis, but is measured at fair value for disclosure purposes (Note 7).